Arprinocid

Arprinocid

SCHEMBL29801468

[3H]c1nc2c(N)ncnc2n1Cc1c(F)cccc1Cl

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 4/20 0.45
▸ PI4K2B Q8TCG2 4/20 0.45
▸ PI4K2A Q9BTU6 4/20 0.45
▸ PI4KB Q9UBF8 4/20 0.45
▸ ADORA2A P29274 2/20 0.45
▸ LMNA P02545 6/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.42
▸ ALDH1A1 P00352 6/20 0.41
▸ TSHR P16473 5/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ PKM P14618 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ GPR55 Q9Y2T6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arprinocid SCHEMBL8375355 0.88 ADORA2A (0.60) PI4KAPI4K2BPI4K2API4KBADORA2A
Arprinocid SCHEMBL31379008 0.88 ADORA2A (0.60) PI4KAPI4K2BPI4K2API4KBADORA2A
Arprinocid SCHEMBL31025603 0.88 ADORA2A (0.60) PI4KAPI4K2BPI4K2API4KBADORA2A
Arprinocid SCHEMBL126655 0.88 ADORA2A (0.60) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL10962832 0.78 ADORA2A (0.68) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL11016348 0.78 ADORA2A (0.63) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL11812620 0.73 ADORA2A (0.60) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL11807952 0.73 ADORA2A (0.60) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL11462599 0.72 SMN1; SMN2 (0.84) LMNASMN1; SMN2HSD17B10ALDH1A1TSHR
SCHEMBL11565162 0.72 ALDH1A1 (0.56) LMNASMN1; SMN2HSD17B10ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916215-A Transdermal microdosing delivery of hallucinogen derivatives 长矛治疗股份有限公司 2023-04-04 — — CN disclosed
US-11607458-B2 Enrichment-triggered chemical delivery system GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2023-03-21 — — US disclosed
CN-115038451-A Multimodal compositions and methods of treatment 阿奎斯蒂弗医疗股份有限公司 2022-09-09 — — CN disclosed
CN-115003279-A Prodrug compositions and methods of treatment 阿奎斯蒂弗医疗股份有限公司 2022-09-02 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11607458-B2 Enrichment-triggered chemical delivery system HMGB1, PAICS, CCL2 PI4KA 2878/4885PI4K2B 3483/4885PI4K2A 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback